TARO-AMLODIPINE
Identification of Taro-Amlodipine
| No description |
Google image searchProduct monograph
Active ingredient
amlodipine (amlodipine besylate), 5 MG
DIN: 02321858
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUN PHARMA CANADA INC
Date: 29-DEC-2020
ATC:
- C08 — CALCIUM CHANNEL BLOCKERS (ATC, ATC/DDD, )
- C08C — SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS (ATC, ATC/DDD)
- C08CA — Dihydropyridine derivatives (ATC, ATC/DDD)
- C08CA01 — AMLODIPINE (ATC/DDD)
Reference brand drug: Norvasc
Pharmaceutical standard: USP
